Home
>
US Stocks
>
Biogen Inc
Biogen Inc
BIIB

Biogen Inc

$268.030.63%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
270.39
Today Low/High
266.39 / 271.53
52 Week Low/High
$223.25 / $468.55
P/E ratio
20.83
Market Cap
$39.96B

Company Details

At Biogen, mission is clear: company is pioneer in neuroscience. Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world's first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp. Today Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer's disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, neuropsychiatry, immunology, acute neurology and neuropathic pain.
Organisation
Biogen Inc
Headquaters
Cambridge, Massachusetts, US
Employees
9.1K
Industry
Health Technology
CEO
George Scangos
Company Financials
  • Annual P&L
  • Quarterly P&L

Discover more

Frequently Asked Questions

What is Biogen Inc share price today

Can Indians buy Biogen Inc shares?

How can I buy Biogen Inc shares from India?

Can Fractional shares of Biogen Inc be purchased?

What are the documents required to start investing in Biogen Inc stocks?

We are a SEBI registered investement advisor